Evaluation of the effects of celecoxib on mouse lymphoma cells (EL4)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

EMAMI L.; SAFI SH.; ZAKER F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF COMPARATIVE PATHOBIOLOGY IRAN Year:2019 | Volume:16 | Issue:1 (64) Page(s): 2713-2722

Download Full-Text

Persian Verion

View:

496

Download:

Cites:

Information Journal Paper

Title

Evaluation of the effects of celecoxib on mouse lymphoma cells (EL4)

Author(s)

EMAMI L. | SAFI SH. | ZAKER F. | Issue Writer Certificate

Keywords

CelecoxibQ1

ApoptosisQ2

EL4 cell lineQ1

MouseQ1

LymphomaQ2

Abstract

Lymphoma is one of the most common tumors in most species of the Mouse. On the other hand, biologic, histopathologic and epidemiological characteristics of Mouse Lymphoma are similar to Lymphoma in humans. Hence, tumor Lymphoma in mice can be a suitable model for the biological study of human cancers. The objective of the present study was to evaluate the apoptotic and cytotoxic effects of Celecoxib on Mouse Lymphoma tumor cells (EL4) using Annexin/PI and MTT assays. The results of MTT showed a dose and time-dependent inhibition of EL4 cells by Celecoxib and 50% inhibition of cell survival at 20 μ m of Celecoxib. In addition, the percentage of cells with Apoptosis increased after 48 hours exposure to IC50 concentration (50% survival of the exposed cells) of Celecoxib. Based on the obtained results, it seems that Celecoxib can be used as an adjunct therapy along with other compounds used to treat Lymphoma in mice and probably in human medicine.

Cites

No record.

References

No record.

Cite

APA: Copy

EMAMI, L., SAFI, SH., & ZAKER, F.. (2019). Evaluation of the effects of celecoxib on mouse lymphoma cells (EL4). JOURNAL OF COMPARATIVE PATHOBIOLOGY IRAN, 16(1 (64) ), 2713-2722. SID. https://sid.ir/paper/197396/en

Vancouver: Copy

EMAMI L., SAFI SH., ZAKER F.. Evaluation of the effects of celecoxib on mouse lymphoma cells (EL4). JOURNAL OF COMPARATIVE PATHOBIOLOGY IRAN[Internet]. 2019;16(1 (64) ):2713-2722. Available from: https://sid.ir/paper/197396/en

IEEE: Copy

L. EMAMI, SH. SAFI, and F. ZAKER, “Evaluation of the effects of celecoxib on mouse lymphoma cells (EL4),” JOURNAL OF COMPARATIVE PATHOBIOLOGY IRAN, vol. 16, no. 1 (64) , pp. 2713–2722, 2019, [Online]. Available: https://sid.ir/paper/197396/en

Related Journal Papers